Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 1/20 | 0.79 |
| ▸ | USP2 | O75604 | 1/20 | 0.69 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.60 |
| ▸ | TSHR | P16473 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.58 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.57 |
| ▸ | HPGD | P15428 | 1/20 | 0.56 |
| ▸ | HTT | P42858 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19546873 | 1.00 | POLB (0.79) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL10038046 | 1.00 | POLB (0.79) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL28354072 | 1.00 | POLB (0.79) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL10014710 | 0.90 | USP2 (0.76) | POLBUSP2KMT2AKDM4ETSHR | |
| SCHEMBL5512058 | 0.90 | POLB (0.65) | POLBUSP2KDM4ETSHRCYP3A4 | |
| SCHEMBL4020740 | 0.87 | TSHR (0.66) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL5514868 | 0.85 | KMT2A (0.62) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL4547282 | 0.85 | POLB (0.59) | POLBUSP2KDM4ETSHRCYP3A4 | |
| SCHEMBL8402141 | 0.84 | POLB (0.63) | POLBUSP2MEN1KMT2AKDM4E | |
| SCHEMBL15093017 | 0.83 | USP2 (0.67) | POLBUSP2KMT2AKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119019649-B | Cycloolefin polymer and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-119019649-A | Cycloolefin polymer and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2024-11-26 | — | — | CN | claimed |
| US-7655688-B2 | Treating nuclear hormone receptor-associated conditions such as cancer and immune disorders; (3a alpha ,4 alpha ,7 alpha ,7a alpha )-2-(3-Chloro-4-hydroxyphenyl)hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione | BRISTOL-MYERS SQUIBB COMPANY (US) | 2010-02-02 | — | — | US | claimed |
| US-20060111424-A1 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | SALVATI MARK E | 2006-05-25 | — | — | US | claimed |
| US-20040087548-A1 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | BRISTOL-MYERS SQUIBB COMPANY | 2004-05-06 | — | — | US | claimed |
| US-4080491-A | CATALYST CONTAINS ORGANOMETALLIC COMPOUND AND THE REACTION PRODUCT OF TUNGSTEN OR MOLYBDENUM OXIDE AND A PHOSPHOROUS HALIDE OR OXYHALIDE | SHOWA DENKO K.K. (JA) | 1978-03-21 | — | — | US | claimed |
| CN-119019649-B | Cycloolefin polymer and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2025-06-03 | — | — | CN | disclosed |
| WO-2025100416-A1 | CYCLIC OLEFIN RING-OPENED POLYMER, CYCLIC OLEFIN RING-OPENED POLYMER HYDRIDE, RESIN COMPOSITION, AND RESIN MOLDED BODY | 日本ゼオン株式会社 | 2025-05-15 | — | — | WO | disclosed |
| CN-119462808-A | Preparation method of 1 alpha-hydroxy bisnoralcohol | 浙江工业大学 | 2025-02-18 | — | — | CN | disclosed |
| CN-119019649-A | Cycloolefin polymer and preparation method thereof | 中石油(上海)新材料研究院有限公司 | 2024-11-26 | — | — | CN | disclosed |
| WO-2024130537-A1 | ELECTROLYTE, ELECTROCHEMICAL APPARATUS AND ELECTRONIC APPARATUS | 东莞新能源科技有限公司 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024130535-A1 | ELECTROCHEMICAL DEVICE AND ELECTRONIC DEVICE | 东莞新能源科技有限公司 | 2024-06-27 | — | — | WO | disclosed |
| CN-111538209-B | Photosensitive resin composition, organic EL element partition wall, and organic EL element | 日保丽公司 | 2024-05-14 | — | — | CN | disclosed |
| US-4105608-A | HIGH IMPACT COMPOSITION OF RING-OPENING POLYMERIZATION PRODUCT | SHOWA DENKO K.K. (JP) | 1978-08-08 | — | — | US | disclosed |
| US-4080491-A | CATALYST CONTAINS ORGANOMETALLIC COMPOUND AND THE REACTION PRODUCT OF TUNGSTEN OR MOLYBDENUM OXIDE AND A PHOSPHOROUS HALIDE OR OXYHALIDE | SHOWA DENKO K.K. (JA) | 1978-03-21 | — | — | US | disclosed |
| US-4068063-A | Catalyst composition for ring-opening polymerization of norbornene derivatives and process for polymerizing same | JAPAN SYNTHETIC RUBBER CO., LTD. (JA) | 1978-01-10 | — | — | US | disclosed |
| US-4059561-A | AND A HALOGEN COMPOUND | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1977-11-22 | — | — | US | disclosed |
| US-4028482-A | LOW VISCOSITY POLYALKENAMER | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1977-06-07 | — | — | US | disclosed |
| US-3991139-A | NORBORNENE DERIVATIVES, PHENOLS, ESTER THIOETHERS | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-11-09 | — | — | US | disclosed |
| US-3959234-A | CATALYSTS OF ORGANOALUMINUM COMPOUNDS AND A TUNGSTEN OR MOLYBDENUM COMPOUND, RING-OPENING | SHOWA DENKO KABUSHIKI KAISHA (JA) | 1976-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040087548-A1 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | NCOA1, ESRRA, NR5A1 | POLB 3096/4885USP2 1946/4885MEN1 1676/4885 |
| US-20060111424-A1 | Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function | NCOA1, ESRRA, NR5A1 | POLB 3096/4885USP2 1946/4885MEN1 1676/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.